A detailed history of Jane Street Group, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 446,185 shares of DVAX stock, worth $5.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
446,185
Previous 686,693 35.02%
Holding current value
$5.66 Million
Previous $7.71 Million 35.55%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $11.61 $2.42 Million - $2.79 Million
-240,508 Reduced 35.02%
446,185 $4.97 Million
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $5.99 Million - $7.02 Million
558,002 Added 433.6%
686,693 $7.71 Million
Q1 2024

May 15, 2024

BUY
$11.7 - $14.98 $1.18 Million - $1.52 Million
101,163 Added 367.49%
128,691 $1.6 Million
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $203,772 - $233,193
15,567 Added 130.15%
27,528 $384,000
Q3 2023

Nov 14, 2023

SELL
$12.64 - $14.99 $1.69 Million - $2.01 Million
-133,879 Reduced 91.8%
11,961 $176,000
Q2 2023

Aug 14, 2023

BUY
$9.85 - $13.17 $95,318 - $127,446
9,677 Added 7.11%
145,840 $1.88 Million
Q1 2023

May 15, 2023

BUY
$9.44 - $11.88 $501,632 - $631,291
53,139 Added 64.0%
136,163 $1.34 Million
Q4 2022

Feb 14, 2023

SELL
$10.27 - $13.29 $354,202 - $458,358
-34,489 Reduced 29.35%
83,024 $883,000
Q3 2022

Nov 14, 2022

SELL
$9.93 - $17.44 $275,696 - $484,204
-27,764 Reduced 19.11%
117,513 $1.23 Million
Q2 2022

Aug 16, 2022

BUY
$7.45 - $12.83 $501,206 - $863,151
67,276 Added 86.25%
145,277 $1.83 Million
Q1 2022

May 17, 2022

SELL
$9.75 - $14.44 $984,789 - $1.46 Million
-101,004 Reduced 56.43%
78,001 $846,000
Q4 2021

Feb 15, 2022

SELL
$13.17 - $20.94 $2.18 Million - $3.47 Million
-165,669 Reduced 48.07%
179,005 $2.52 Million
Q3 2021

Nov 16, 2021

BUY
$9.16 - $19.83 $1.62 Million - $3.51 Million
177,180 Added 105.78%
344,674 $6.62 Million
Q2 2021

Aug 16, 2021

SELL
$7.25 - $10.99 $238,626 - $361,724
-32,914 Reduced 16.42%
167,494 $1.65 Million
Q1 2021

May 18, 2021

BUY
$4.57 - $11.18 $708,838 - $1.73 Million
155,107 Added 342.39%
200,408 $1.97 Million
Q4 2020

Feb 17, 2021

SELL
$3.73 - $5.6 $343,741 - $516,073
-92,156 Reduced 67.04%
45,301 $201,000
Q3 2020

Nov 17, 2020

BUY
$4.32 - $11.7 $526,180 - $1.43 Million
121,801 Added 777.98%
137,457 $593,000
Q2 2020

Aug 17, 2020

BUY
$2.94 - $9.1 $46,028 - $142,469
15,656 New
15,656 $139,000
Q1 2020

May 15, 2020

SELL
$2.27 - $6.2 $69,425 - $189,620
-30,584 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.46 - $6.93 $105,820 - $211,947
30,584 New
30,584 $175,000
Q3 2019

Nov 14, 2019

SELL
$2.69 - $4.85 $134,543 - $242,577
-50,016 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$3.65 - $7.89 $140,521 - $303,757
38,499 Added 334.28%
50,016 $200,000
Q1 2019

May 16, 2019

SELL
$7.08 - $12.09 $19,788 - $33,791
-2,795 Reduced 19.53%
11,517 $84,000
Q4 2018

Feb 15, 2019

SELL
$8.14 - $13.28 $184,379 - $300,805
-22,651 Reduced 61.28%
14,312 $131,000
Q3 2018

Nov 14, 2018

BUY
$11.85 - $16.0 $87,761 - $118,496
7,406 Added 25.06%
36,963 $458,000
Q1 2018

May 15, 2018

BUY
$14.65 - $19.9 $125,242 - $170,125
8,549 Added 40.69%
29,557 $587,000
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $319,321 - $451,672
21,008
21,008 $452,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.